Mandate

Vinge advises on transactions between Platzer and Länsförsäkringar

April 12, 2019 Private Equity

Vinge has advised Platzer Fastigheter in connection with the company’s entry into of an agreement with Länsförskringar Göteborg and Bohuslän concerning the transfer of half of the participating interests in the subsidiary with owns the property Gårda Vesta.

A building is currently being erected on the property which will include approximately 27 800 m2 of office space and will be completed in 2021. The parties have also entered into a lease agreement whereby Länsförsäkringar will rent 5 360 m2 of office space in Gårda Vesta. Since Länsförsäkringar is one of the largest shareholders in Platzer Fastigheter, the transaction was approved by the annual general meeting in 2018. The asset purchase agreement and lease agreement have been included in the same resolution adopted at the annual general meeting. As of the date of the annual general meeting, the property was valued at MSEK 1 300.

Vinge’s team primarily consisted of Olof Jisland, Assur Badur, Kristoffer Larson, Ulf Nilsson, Victor Ericsson and Nils Fredrik Dehlin.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025